Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,729.48
(
0.45%
)
US TECH 100
24,164.80
(
0.62%
)
Dow Jones
47,098.72
(
0.32%
)
Brent Oil
100.49
(
2.22%
)
Bitcoin
74,675.81
(
-0.22%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 149064

Friday, 09/21/2012 8:51:27 AM

Friday, September 21, 2012 8:51:27 AM

Post# of 257251
EU’s CHMP approves Eliquis for AF/stroke prevention:

http://news.bms.com/press-release/rd-news/eliquis-apixaban-receives-chmp-positive-opinion-prevention-stroke-and-systemic&t=634838120756189628

This will be Eliquis’ largest indication. Eliquis was approved in the EU for VTE prevention following hip/knee surgery in 2011.

In the US, BMY/PFE are responding to a CRL issued in June for the Eliquis NDA in AF (#msg-76926354).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now